vs
Side-by-side financial comparison of Iridium Communications Inc. (IRDM) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($311.4M vs $219.1M, roughly 1.4× Iridium Communications Inc.). Bio-Techne runs the higher net margin — 16.4% vs 9.9%, a 6.5% gap on every dollar of revenue. On growth, Iridium Communications Inc. posted the faster year-over-year revenue change (1.9% vs -1.5%). Over the past eight quarters, Iridium Communications Inc.'s revenue compounded faster (4.4% CAGR vs 1.3%).
Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
IRDM vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $219.1M | $311.4M |
| Net Profit | $21.6M | $51.0M |
| Gross Margin | — | 66.9% |
| Operating Margin | 23.2% | 24.2% |
| Net Margin | 9.9% | 16.4% |
| Revenue YoY | 1.9% | -1.5% |
| Net Profit YoY | — | 126.0% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $219.1M | $311.4M | ||
| Q4 25 | $212.9M | $295.9M | ||
| Q3 25 | $226.9M | — | ||
| Q2 25 | $216.9M | $317.0M | ||
| Q1 25 | $214.9M | $316.2M | ||
| Q4 24 | $213.0M | $297.0M | ||
| Q3 24 | $212.8M | $289.5M | ||
| Q2 24 | $201.1M | $306.1M |
| Q1 26 | $21.6M | $51.0M | ||
| Q4 25 | $24.9M | $38.0M | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $22.0M | $-17.7M | ||
| Q1 25 | $30.4M | $22.6M | ||
| Q4 24 | $36.3M | $34.9M | ||
| Q3 24 | $24.4M | $33.6M | ||
| Q2 24 | $32.3M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | 23.2% | 24.2% | ||
| Q4 25 | 25.9% | 18.4% | ||
| Q3 25 | 30.9% | — | ||
| Q2 25 | 23.2% | -7.5% | ||
| Q1 25 | 28.1% | 12.2% | ||
| Q4 24 | 24.5% | 16.0% | ||
| Q3 24 | 25.8% | 13.8% | ||
| Q2 24 | 21.7% | 15.0% |
| Q1 26 | 9.9% | 16.4% | ||
| Q4 25 | 11.7% | 12.8% | ||
| Q3 25 | 16.4% | — | ||
| Q2 25 | 10.1% | -5.6% | ||
| Q1 25 | 14.2% | 7.1% | ||
| Q4 24 | 17.1% | 11.7% | ||
| Q3 24 | 11.5% | 11.6% | ||
| Q2 24 | 16.1% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.24 | $0.24 | ||
| Q3 25 | $0.35 | — | ||
| Q2 25 | $0.20 | $-0.11 | ||
| Q1 25 | $0.27 | $0.14 | ||
| Q4 24 | $0.30 | $0.22 | ||
| Q3 24 | $0.21 | $0.21 | ||
| Q2 24 | $0.27 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $209.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.1B |
| Total Assets | — | $2.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $96.5M | $172.9M | ||
| Q3 25 | $88.5M | — | ||
| Q2 25 | $79.3M | $162.2M | ||
| Q1 25 | $50.9M | $140.7M | ||
| Q4 24 | $93.5M | $177.5M | ||
| Q3 24 | $159.6M | $187.5M | ||
| Q2 24 | $63.5M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $1.8B | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $462.6M | $2.0B | ||
| Q3 25 | $450.5M | — | ||
| Q2 25 | $473.6M | $1.9B | ||
| Q1 25 | $518.4M | $2.0B | ||
| Q4 24 | $576.6M | $2.1B | ||
| Q3 24 | $663.8M | $2.1B | ||
| Q2 24 | $786.7M | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.5B | $2.5B | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | $2.6B | ||
| Q1 25 | $2.6B | $2.6B | ||
| Q4 24 | $2.7B | $2.7B | ||
| Q3 24 | $2.8B | $2.7B | ||
| Q2 24 | $2.7B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 3.80× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 3.05× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRDM
| Voice and data | $57.4M | 26% |
| IoT data (2) | $46.0M | 21% |
| Government | $39.5M | 18% |
| Government service revenue (5) | $27.6M | 13% |
| Subscriber equipment | $20.2M | 9% |
| Hosted payload and other data service (4) | $14.8M | 7% |
| Broadband (3) | $12.2M | 6% |
| Commercial | $1.3M | 1% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
